Assessing the cardiology community position on transradial intervention and the use of bivalirudin in patients with acute coronary syndrome undergoing invasive management: results of an EAPCI survey

Adamo, MariannaMariannaAdamoByrne, Robert ARobert AByrneBaumbach, AndreasAndreasBaumbachHaude, MichaelMichaelHaudeWindecker, StephanStephanWindeckerValgimigli, MarcoMarcoValgimigliAaroe J.Abdeltawab A.A.Accardi R.Addad F.Agostoni P.Alajab A.TZUNG-DAU WANG2024-03-202024-03-202016-10-201774024Xhttps://www.scopus.com/record/display.uri?eid=2-s2.0-84994614045&doi=10.4244%2fEIJY15M12_01&origin=inward&txGid=a74e4332df43bdc0639740c34abb42b2https://scholars.lib.ntu.edu.tw/handle/123456789/641139Our aim was to report on a survey initiated by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) collecting the opinion of the cardiology community on the invasive management of acute coronary syndrome (ACS), before and after the MATRIX trial presentation at the American College of Cardiology (ACC) 2015 Scientific Sessions.enAcute coronary syndrome | Bivalirudin | Transradial[SDGs]SDG3Assessing the cardiology community position on transradial intervention and the use of bivalirudin in patients with acute coronary syndrome undergoing invasive management: results of an EAPCI surveyjournal article10.4244/EIJY15M12_01266747372-s2.0-84994614045https://api.elsevier.com/content/abstract/scopus_id/84994614045